Lab-Grown Eye Cells Restore Vision in Mice, Offering Real Hope for the Blind

Scientists at Duke University have achieved something that seemed like science fiction just a few years ago: they’ve grown retinal blood vessel cells from stem cells in a lab, injected them into mice with eye disease, and watched those cells integrate seamlessly into damaged tissue to restore vision.

Here’s why that matters. Diabetic retinopathy—damage to the blood vessels in the retina caused by diabetes—is the leading cause of blindness in working-age Americans. It happens quietly. The tiny, specialized blood vessels that feed the retina start to fail, and vision deteriorates. Until now, there’s been no good way to fix it. The retinal endothelial cells that form these critical vessels are so specialized that they can only be harvested from real patient tissue, making them expensive, limited in supply, and hard to scale for treatment.

But biomedical engineer Professor Sharon Gerecht and her team found a workaround using induced pluripotent stem cells (iPSCs)—the technology that earned Shinya Yamanaka a Nobel Prize in 2012. These are adult cells that have been“reprogrammed”back into a pluripotent state, meaning they can become any cell type in the body. The researchers used a specialized chemical cocktail to coax iPSCs into becoming the exact endothelial cells found in retinal blood vessels. In lab experiments, they even subjected the cells to low oxygen and high glucose—the same punishing conditions that trigger diabetic retinopathy in real patients—and the cells held up, maintaining the blood-brain barrier that keeps the retina healthy.

When the team injected these lab-grown cells into mice before vision loss occurred, something remarkable happened. The cells integrated into existing retinal tissue and helped build strong, functional blood vessels with robust barriers. The mice didn’t lose their sight. That’s preventative power, not just damage control.

Parker Esswein, a PhD student in the Gerecht lab and first co-author of the research published in Nature Biomedical Engineering, notes that the breakthrough opens doors beyond therapy.“While our benchtop experiments did not attempt to model a wide variety of specific eye diseases in these studies, we’re confident we can create excellent human tissue models in the lab to help better understand these diseases and uncover therapies.”In other words, these cells can become a testing ground for new drugs, accelerating discovery.

The road from mice to humans is long, and the team has a patent pending that covers both the stem cell therapeutics and lab-based drug discovery models. But for millions of people living with diabetic retinopathy and other retinal diseases, this breakthrough signals something real: a future where vision loss might be preventable, affordable, and repeatable. That’s not hope—that’s a roadmap.